title: Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease.
authors.affiliation: University of Milano Bicocca, Section of Hematology, Ospedale S.Gerardo, Via Cadore 48, 20052 Monza, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Franceschino
authors.forename: Lucia
authors.initials: L
authors.lastname: Tornaghi
authors.forename: Rocco
authors.initials: R
authors.lastname: Piazza
authors.forename: Enrico
authors.initials: E
authors.lastname: Pogliani
authors.forename: Carlo
authors.initials: C
authors.lastname: Gambacorti Passerini
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D004334:Drug Administration Schedule; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D018365:Neoplasm, Residual / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate